Related Experiment Videos
Improved clinical facility for in vivo nitrogen measurement
S S Krishnan1, K G McNeill, J R Mernagh
1Toronto General Hospital, Medical Physics Department, Ontario, Canada.
Physics in Medicine and Biology
|April 1, 1990
Summary
This study details a hospital facility for in vivo prompt gamma neutron activation analysis to measure total body nitrogen (TBN). Using Californium-252 (252Cf) sources improves measurement reproducibility and signal-to-background ratio for accurate TBN assessment.
Area of Science:
- Medical Physics
- Nuclear Medicine
- Biomedical Engineering
Background:
- Accurate measurement of total body nitrogen (TBN) is crucial for assessing nutritional status and various metabolic conditions.
- Existing methods for TBN measurement have limitations in reproducibility and signal-to-background ratios.
- Development of a dedicated clinical facility is needed for efficient and reliable in vivo TBN analysis.
Purpose of the Study:
- To describe the design and construction of a hospital clinical facility for in vivo prompt gamma neutron activation analysis (PGNAA).
- To evaluate the performance of Californium-252 (252Cf) neutron sources for TBN measurement compared to Plutonium-Beryllium (238Pu-Be) sources.
- To optimize measurement techniques for improved signal-to-background ratio and reproducibility.
Main Methods:
- Utilized a 252Cf neutron source for prompt gamma neutron activation analysis.
- Implemented gating circuits to separately measure hydrogen and nitrogen signals, enhancing the signal-to-background ratio.
- Conducted measurements using a urea phantom and assessed reproducibility for nitrogen and hydrogen signals.
- Evaluated patient measurement time, radiation dose, and data processing efficiency.
Main Results:
- 252Cf sources yielded a superior nitrogen signal-to-background ratio (5.6) compared to 238Pu-Be sources (3.4).
- Achieved high reproducibility for nitrogen signal (+/- 1.1% CV) and hydrogen signal (+/- 2.33% CV).
- TBN measurement requires approximately 30 minutes per patient with an overall reproducibility of +/- 3.8% (CV) and a low radiation dose (0.2 mSv).
Conclusions:
- The designed clinical facility provides a clean, comfortable, and economical setup for in vivo TBN measurement using PGNAA.
- The use of 252Cf sources and optimized gating circuits significantly improves measurement accuracy and reproducibility.
- This facility offers a practical and efficient method for clinicians to obtain rapid and reliable TBN data.